PCSK9 Inhibitors Might Benefit Patients with LDL-C Level <70 mg/dL

2021

In patients with very-high-risk atherosclerotic cardiovascular disease, current guidelines recommend adding a nonstatin medication to statin therapy if

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

0

References

0

Citations